| Title |
Patient Adherence and Persistence with Imatinib, Nilotinib, Dasatinib in Clinical Practice
|
|---|---|
| Published in |
PLOS ONE, February 2013
|
| DOI | 10.1371/journal.pone.0056813 |
| Pubmed ID | |
| Authors |
Fiorenzo Santoleri, Paola Sorice, Ruggero Lasala, Rosa Carmela Rizzo, Alberto Costantini |
| Abstract |
The aim of this study is to evaluate adherence and persistence of patients treated with Imatinib, Nilotinib or Dasatinib, also giving economic evaluations on therapy costs for Received Daily Dose (RDD). |
X Demographics
The data shown below were collected from the profiles of 3 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 3 | 100% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 3 | 100% |
Mendeley readers
The data shown below were compiled from readership statistics for 81 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Indonesia | 1 | 1% |
| United Kingdom | 1 | 1% |
| Spain | 1 | 1% |
| France | 1 | 1% |
| Unknown | 77 | 95% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Master | 11 | 14% |
| Researcher | 10 | 12% |
| Student > Bachelor | 8 | 10% |
| Student > Ph. D. Student | 7 | 9% |
| Other | 6 | 7% |
| Other | 17 | 21% |
| Unknown | 22 | 27% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 23 | 28% |
| Pharmacology, Toxicology and Pharmaceutical Science | 14 | 17% |
| Biochemistry, Genetics and Molecular Biology | 5 | 6% |
| Nursing and Health Professions | 4 | 5% |
| Agricultural and Biological Sciences | 4 | 5% |
| Other | 10 | 12% |
| Unknown | 21 | 26% |